SEC 13F Intelligence

Point72 Europe (London) LLP / IART

Point72 Europe (London) LLP’s Integra Lifesciences Hldgs C Position

Does Point72 Europe (London) LLP own Integra Lifesciences Hldgs C (IART)? Not currently — the last reported position was 546.0K shares worth $16M in Q2 2024; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$16M
Q2 2024
Shares
546.0K
% of Portfolio
+1.31%
Quarters Held
5
position exited

Position History IART

Reported value by quarter
Q2 ’23: $575,820Q2 ’23Q3 ’23: $18MQ3 ’23Q4 ’23: $31MQ4 ’23Q1 ’24: $17MQ1 ’24Q2 ’24: $16MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2024546.0K$16M+1.31%
Q1 2024479.6K$17M+1.52%
Q4 2023719.7K$31M+3.93%
Q3 2023464.5K$18M+1.09%
Q2 202314.0K$575,820+0.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Point72 Europe (London) LLP’s full portfolio or all institutional holders of IART.